U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Confusion reigns over the Trump administration’s potential public offering for mortgage giants Fannie Mae and Freddie Mac ...

A group of investors led by one of the country’s biggest hotel owners struck a deal to take Soho House private, ending a ...

Wall Street ticked modestly lower ahead of U.S. President Donald Trump’s meeting with Ukrainian President Volodymyr Zelenskyy ...

Stocks are still flying high. But doubts are creeping in about the S&P 500’s run, as some analysts have flashbacks to ...

The conservative newspaper's editorial board has a message for Trump ahead of his meeting with Ukrainian President Volodymyr ...

The following two companies have seen their share prices collapse over the past few years due to macroeconomic headwinds.

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.

U.S. stock futures are lower after last week's gains on increased expectations for a Federal Reserve rate cut in September.

The ACLU has warned of constitutional risks as the Trump administration expands its deployment of federal law enforcement and ...

NVIDIA Corporation (NASDAQ:NVDA) is one of the Must-Watch AI Stocks on Wall Street. On August 13, Mizuho analyst Vijay Rakesh ...